Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Symbotic Inc (SYM) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Symbotic IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Symbotic Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Symbotic Inc trades at $37.59 (market cap $5.31B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Symbotic Inc is far larger — about 3× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Symbotic Inc for 24 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SYMVIR
Market Cap
$5.31B$1.80B
Volume
1,244,3391,782,836
Sector
IndustrialsHealth
52-Week High
$87.30$11.78
52-Week Low
$37.90$5.12
Typical Hold Time
24 Days0 Days
Enterprise Value
$3.56B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Symbotic Inc

SYM trades at $40.89, down 32% year-to-date and near 52-week lows, with bearish technical signals dominating. Fundamentally, the company shows mixed results with a $22.5 billion backlog and 20%+ revenue growth but negative EBITDA of -$48M and net loss of -$17M in 2025. Recent earnings misses and high customer concentration (85% revenue from Walmart) create uncertainty despite analyst optimism.

The stock presents a high-risk opportunity with significant upside potential if execution improves. Analyst consensus targets $60.33 (47% upside) but near-term risks include continued earnings misses, customer concentration, and weak technical momentum. The 2027 inflection point for new system deployments represents the key growth catalyst.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SYM
100% Buy0% Sell
Avg holding period · 24 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Symbotic Inc

Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.

Read more on SYM →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →